Cargando…
Protocol for generation of lung adenocarcinoma organoids from clinical samples
Human cancer tissue-derived organoids maintain the mutational spectrum and histological characteristics of their parental tumors and thus provide a platform for predicting patients’ responses to anticancer drugs. Here, we provide a fully detailed, step-by-step protocol to derive lung adenocarcinoma...
Autores principales: | Li, Zhichao, Yu, Lei, Chen, Dong, Meng, Zhaoyue, Chen, Wei, Huang, Weiren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779824/ https://www.ncbi.nlm.nih.gov/pubmed/33426535 http://dx.doi.org/10.1016/j.xpro.2020.100239 |
Ejemplares similares
-
Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2020) -
Protocol for generating reproducible miniaturized controlled midbrain organoids
por: Chen, Muwan, et al.
Publicado: (2023) -
Generation of human embryonic stem cell-derived lung organoids
por: Han, Le, et al.
Publicado: (2022) -
A robust protocol for the generation of human midbrain organoids
por: Zagare, Alise, et al.
Publicado: (2021) -
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
por: Liu, Lisa, et al.
Publicado: (2021)